nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—Antazoline—HRH1—atherosclerosis	0.0229	0.629	CrCbGaD
Naphazoline—Endophthalmitis—Pravastatin—atherosclerosis	0.0176	0.108	CcSEcCtD
Naphazoline—Tolazoline—HRH1—atherosclerosis	0.0135	0.371	CrCbGaD
Naphazoline—Redness—Niacin—atherosclerosis	0.0126	0.0776	CcSEcCtD
Naphazoline—Sweating—Niacin—atherosclerosis	0.00457	0.0281	CcSEcCtD
Naphazoline—Erythema—Ezetimibe—atherosclerosis	0.00425	0.0262	CcSEcCtD
Naphazoline—Vision blurred—Lovastatin—atherosclerosis	0.00409	0.0251	CcSEcCtD
Naphazoline—Erythema—Simvastatin—atherosclerosis	0.00406	0.0249	CcSEcCtD
Naphazoline—Eye disorder—Niacin—atherosclerosis	0.004	0.0246	CcSEcCtD
Naphazoline—Vision blurred—Simvastatin—atherosclerosis	0.00382	0.0235	CcSEcCtD
Naphazoline—Erythema—Niacin—atherosclerosis	0.00372	0.0229	CcSEcCtD
Naphazoline—Hypertension—Ezetimibe—atherosclerosis	0.00367	0.0226	CcSEcCtD
Naphazoline—Tension—Niacin—atherosclerosis	0.00365	0.0225	CcSEcCtD
Naphazoline—Discomfort—Lovastatin—atherosclerosis	0.00365	0.0224	CcSEcCtD
Naphazoline—Nervousness—Niacin—atherosclerosis	0.00362	0.0222	CcSEcCtD
Naphazoline—Tension—Pravastatin—atherosclerosis	0.0036	0.0221	CcSEcCtD
Naphazoline—Discomfort—Ezetimibe—atherosclerosis	0.00358	0.022	CcSEcCtD
Naphazoline—Nervousness—Pravastatin—atherosclerosis	0.00356	0.0219	CcSEcCtD
Naphazoline—Vision blurred—Niacin—atherosclerosis	0.00351	0.0216	CcSEcCtD
Naphazoline—Vision blurred—Pravastatin—atherosclerosis	0.00346	0.0213	CcSEcCtD
Naphazoline—Discomfort—Simvastatin—atherosclerosis	0.00341	0.021	CcSEcCtD
Naphazoline—Hypertension—Pravastatin—atherosclerosis	0.00317	0.0195	CcSEcCtD
Naphazoline—Discomfort—Pravastatin—atherosclerosis	0.00308	0.019	CcSEcCtD
Naphazoline—Asthenia—Rosuvastatin—atherosclerosis	0.003	0.0184	CcSEcCtD
Naphazoline—Hyperhidrosis—Niacin—atherosclerosis	0.00294	0.0181	CcSEcCtD
Naphazoline—Hyperhidrosis—Pravastatin—atherosclerosis	0.00289	0.0178	CcSEcCtD
Naphazoline—Dizziness—Rosuvastatin—atherosclerosis	0.00276	0.017	CcSEcCtD
Naphazoline—Somnolence—Niacin—atherosclerosis	0.0027	0.0166	CcSEcCtD
Naphazoline—Headache—Rosuvastatin—atherosclerosis	0.00262	0.0161	CcSEcCtD
Naphazoline—Asthenia—Lovastatin—atherosclerosis	0.00254	0.0156	CcSEcCtD
Naphazoline—Asthenia—Ezetimibe—atherosclerosis	0.00249	0.0153	CcSEcCtD
Naphazoline—Nausea—Rosuvastatin—atherosclerosis	0.00248	0.0153	CcSEcCtD
Naphazoline—Asthenia—Simvastatin—atherosclerosis	0.00237	0.0146	CcSEcCtD
Naphazoline—Dizziness—Lovastatin—atherosclerosis	0.00234	0.0144	CcSEcCtD
Naphazoline—Dizziness—Ezetimibe—atherosclerosis	0.0023	0.0141	CcSEcCtD
Naphazoline—Headache—Lovastatin—atherosclerosis	0.00222	0.0136	CcSEcCtD
Naphazoline—Dizziness—Simvastatin—atherosclerosis	0.00219	0.0135	CcSEcCtD
Naphazoline—Asthenia—Niacin—atherosclerosis	0.00218	0.0134	CcSEcCtD
Naphazoline—Headache—Ezetimibe—atherosclerosis	0.00217	0.0134	CcSEcCtD
Naphazoline—Asthenia—Pravastatin—atherosclerosis	0.00215	0.0132	CcSEcCtD
Naphazoline—Nausea—Lovastatin—atherosclerosis	0.0021	0.0129	CcSEcCtD
Naphazoline—Headache—Simvastatin—atherosclerosis	0.00207	0.0128	CcSEcCtD
Naphazoline—Nausea—Ezetimibe—atherosclerosis	0.00206	0.0127	CcSEcCtD
Naphazoline—Dizziness—Niacin—atherosclerosis	0.00201	0.0124	CcSEcCtD
Naphazoline—Dizziness—Pravastatin—atherosclerosis	0.00198	0.0122	CcSEcCtD
Naphazoline—Nausea—Simvastatin—atherosclerosis	0.00197	0.0121	CcSEcCtD
Naphazoline—Headache—Niacin—atherosclerosis	0.0019	0.0117	CcSEcCtD
Naphazoline—Headache—Pravastatin—atherosclerosis	0.00187	0.0115	CcSEcCtD
Naphazoline—Nausea—Niacin—atherosclerosis	0.00181	0.0111	CcSEcCtD
Naphazoline—Nausea—Pravastatin—atherosclerosis	0.00178	0.0109	CcSEcCtD
Naphazoline—ADRA2A—Signaling Pathways—VWF—atherosclerosis	0.000193	0.000241	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	0.000192	0.00024	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOC3—atherosclerosis	0.000192	0.00024	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LDLR—atherosclerosis	0.000191	0.000239	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—TGFB1—atherosclerosis	0.000191	0.000238	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—KNG1—atherosclerosis	0.00019	0.000238	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—HMOX1—atherosclerosis	0.00019	0.000237	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGTR1—atherosclerosis	0.000189	0.000236	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AGT—atherosclerosis	0.000188	0.000235	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	0.000187	0.000234	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL3—atherosclerosis	0.000187	0.000233	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PIK3CG—atherosclerosis	0.000186	0.000232	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CCL2—atherosclerosis	0.000186	0.000232	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PLG—atherosclerosis	0.000184	0.00023	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	0.000184	0.00023	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—MAPK3—atherosclerosis	0.000183	0.000229	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOB—atherosclerosis	0.000182	0.000227	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	0.000182	0.000227	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	0.000182	0.000227	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	0.000181	0.000226	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ABCA1—atherosclerosis	0.00018	0.000225	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000179	0.000224	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NCF1—atherosclerosis	0.000179	0.000223	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—TGFB1—atherosclerosis	0.000178	0.000222	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—KNG1—atherosclerosis	0.000178	0.000222	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GSTM1—atherosclerosis	0.000177	0.000221	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	0.000177	0.000221	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	0.000177	0.000221	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	0.000177	0.000221	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGTR1—atherosclerosis	0.000177	0.000221	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SOCS3—atherosclerosis	0.000175	0.000218	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—F2—atherosclerosis	0.000174	0.000217	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—LPL—atherosclerosis	0.000174	0.000217	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CCL2—atherosclerosis	0.000173	0.000216	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PLG—atherosclerosis	0.000172	0.000215	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AGT—atherosclerosis	0.000171	0.000213	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—F2—atherosclerosis	0.00017	0.000212	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—GPX1—atherosclerosis	0.00017	0.000212	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EDNRA—atherosclerosis	0.000169	0.000211	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCR2—atherosclerosis	0.000169	0.000211	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP3—atherosclerosis	0.000169	0.00021	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CYBA—atherosclerosis	0.000168	0.00021	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF2—atherosclerosis	0.000168	0.00021	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000166	0.000208	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CD36—atherosclerosis	0.000165	0.000206	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—GHRL—atherosclerosis	0.000164	0.000205	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PLAT—atherosclerosis	0.000164	0.000205	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PARP1—atherosclerosis	0.000164	0.000205	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SOCS3—atherosclerosis	0.000163	0.000204	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOB—atherosclerosis	0.000163	0.000203	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000163	0.000203	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—CXCL8—atherosclerosis	0.000162	0.000202	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—EDN1—atherosclerosis	0.00016	0.0002	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL5—atherosclerosis	0.000159	0.000199	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—F2—atherosclerosis	0.000158	0.000197	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—VEGFA—atherosclerosis	0.000158	0.000197	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP3—atherosclerosis	0.000157	0.000197	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF2—atherosclerosis	0.000157	0.000196	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—MTHFR—atherosclerosis	0.000157	0.000195	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LPL—atherosclerosis	0.000156	0.000194	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.000155	0.000194	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.000154	0.000193	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—HMOX1—atherosclerosis	0.000154	0.000193	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARA—atherosclerosis	0.000154	0.000192	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOB—atherosclerosis	0.000152	0.00019	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000152	0.000189	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	0.000151	0.000189	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000151	0.000189	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—CXCL8—atherosclerosis	0.000151	0.000188	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.000151	0.000188	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—EDN1—atherosclerosis	0.00015	0.000187	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—MAPK3—atherosclerosis	0.000149	0.000186	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AGT—atherosclerosis	0.000149	0.000186	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL5—atherosclerosis	0.000149	0.000186	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOB—atherosclerosis	0.000148	0.000185	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	0.000147	0.000184	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	0.000147	0.000183	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOE—atherosclerosis	0.000146	0.000182	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LPL—atherosclerosis	0.000145	0.000181	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—TGFB1—atherosclerosis	0.000145	0.000181	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	0.000144	0.00018	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CAV1—atherosclerosis	0.000144	0.00018	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—APOA1—atherosclerosis	0.000144	0.00018	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GSTM1—atherosclerosis	0.000144	0.00018	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	0.000144	0.000179	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	0.000143	0.000178	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PRKCG—atherosclerosis	0.000141	0.000176	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—LPL—atherosclerosis	0.000141	0.000176	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	0.000141	0.000176	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PLG—atherosclerosis	0.00014	0.000175	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—GPX1—atherosclerosis	0.000138	0.000172	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	0.000138	0.000172	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SPP1—atherosclerosis	0.000138	0.000172	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	0.000137	0.000171	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—CXCL8—atherosclerosis	0.000137	0.000171	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	0.000136	0.00017	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CD36—atherosclerosis	0.000134	0.000167	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AGT—atherosclerosis	0.000133	0.000166	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOB—atherosclerosis	0.000133	0.000166	CbGpPWpGaD
Naphazoline—ADRA2B—Hemostasis—AKT1—atherosclerosis	0.000132	0.000165	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	0.000132	0.000165	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000132	0.000165	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PIK3CG—atherosclerosis	0.000131	0.000164	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	0.000131	0.000163	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOE—atherosclerosis	0.00013	0.000163	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—LEP—atherosclerosis	0.00013	0.000163	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	0.00013	0.000162	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	0.000129	0.000161	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	0.000129	0.000161	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	0.000128	0.00016	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	0.000127	0.000159	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	0.000127	0.000159	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—MTHFR—atherosclerosis	0.000127	0.000159	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LPL—atherosclerosis	0.000127	0.000159	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PPARG—atherosclerosis	0.000127	0.000158	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARA—atherosclerosis	0.000125	0.000156	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	0.000125	0.000155	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—INS—atherosclerosis	0.000124	0.000155	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AGT—atherosclerosis	0.000124	0.000155	CbGpPWpGaD
Naphazoline—ADRA2C—Hemostasis—AKT1—atherosclerosis	0.000124	0.000154	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOB—atherosclerosis	0.000124	0.000154	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	0.000124	0.000154	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—F2—atherosclerosis	0.000123	0.000154	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	0.000123	0.000153	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—LEP—atherosclerosis	0.000122	0.000152	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOE—atherosclerosis	0.000122	0.000152	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	0.000122	0.000152	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AGT—atherosclerosis	0.000121	0.000151	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	0.000121	0.000151	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	0.000121	0.000151	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	0.00012	0.00015	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	0.00012	0.00015	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	0.00012	0.00015	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOE—atherosclerosis	0.000118	0.000148	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LPL—atherosclerosis	0.000118	0.000147	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	0.000118	0.000147	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CAV1—atherosclerosis	0.000117	0.000146	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—APOA1—atherosclerosis	0.000117	0.000146	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	0.000116	0.000145	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—F2—atherosclerosis	0.000115	0.000143	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	0.000115	0.000143	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—ALB—atherosclerosis	0.000114	0.000142	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	0.000113	0.000141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	0.000112	0.00014	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—INS—atherosclerosis	0.000111	0.000139	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	0.000111	0.000139	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	0.000111	0.000139	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	0.00011	0.000137	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	0.00011	0.000137	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—NOS3—atherosclerosis	0.000109	0.000136	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AGT—atherosclerosis	0.000109	0.000136	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	0.000108	0.000135	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PIK3CG—atherosclerosis	0.000107	0.000133	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—LEP—atherosclerosis	0.000107	0.000133	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOE—atherosclerosis	0.000107	0.000133	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	0.000106	0.000132	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	0.000105	0.000131	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	0.000105	0.000131	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—INS—atherosclerosis	0.000104	0.00013	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	0.000103	0.000129	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PPARG—atherosclerosis	0.000103	0.000129	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	0.000102	0.000128	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	0.000102	0.000128	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	0.000102	0.000127	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—INS—atherosclerosis	0.000101	0.000126	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AGT—atherosclerosis	0.000101	0.000126	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	0.000101	0.000126	CbGpPWpGaD
Naphazoline—ADRA2A—Hemostasis—AKT1—atherosclerosis	0.000101	0.000125	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—F2—atherosclerosis	0.0001	0.000125	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—PTGS2—atherosclerosis	9.98e-05	0.000125	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—LEP—atherosclerosis	9.9e-05	0.000124	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOE—atherosclerosis	9.9e-05	0.000124	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	9.8e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	9.78e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	9.77e-05	0.000122	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	9.61e-05	0.00012	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	9.56e-05	0.000119	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	9.45e-05	0.000118	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—F2—atherosclerosis	9.33e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—ALB—atherosclerosis	9.27e-05	0.000116	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	9.21e-05	0.000115	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	9.13e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—INS—atherosclerosis	9.1e-05	0.000114	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	8.95e-05	0.000112	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	8.93e-05	0.000111	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—NOS3—atherosclerosis	8.87e-05	0.000111	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	8.8e-05	0.00011	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	8.67e-05	0.000108	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	8.55e-05	0.000107	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—INS—atherosclerosis	8.45e-05	0.000106	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	8.37e-05	0.000105	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	8.36e-05	0.000104	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	8.32e-05	0.000104	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	8.24e-05	0.000103	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	8.18e-05	0.000102	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—PTGS2—atherosclerosis	8.11e-05	0.000101	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	8.1e-05	0.000101	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	7.98e-05	9.96e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	7.84e-05	9.79e-05	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	7.82e-05	9.76e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	7.76e-05	9.69e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	7.76e-05	9.68e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	7.7e-05	9.61e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	7.62e-05	9.52e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	7.6e-05	9.49e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	7.41e-05	9.25e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	7.32e-05	9.14e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	7.25e-05	9.04e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	7.12e-05	8.89e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	7.1e-05	8.87e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	7.08e-05	8.83e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	7.04e-05	8.79e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	6.97e-05	8.7e-05	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	6.84e-05	8.53e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	6.73e-05	8.4e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	6.66e-05	8.31e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	6.58e-05	8.21e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	6.58e-05	8.21e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	6.51e-05	8.13e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	6.46e-05	8.07e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	6.4e-05	7.99e-05	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	6.35e-05	7.93e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	6.33e-05	7.91e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	6.25e-05	7.81e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	6.23e-05	7.77e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	6.22e-05	7.76e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	6.21e-05	7.75e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	6.04e-05	7.53e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	5.95e-05	7.42e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	5.88e-05	7.35e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	5.78e-05	7.22e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	5.77e-05	7.2e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	5.75e-05	7.18e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	5.69e-05	7.11e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	5.44e-05	6.79e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	5.34e-05	6.67e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	5.29e-05	6.6e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	5.28e-05	6.59e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	5.05e-05	6.31e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—AKT1—atherosclerosis	5.02e-05	6.26e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	4.9e-05	6.12e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—IL6—atherosclerosis	4.87e-05	6.08e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—IL6—atherosclerosis	4.55e-05	5.68e-05	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	4.49e-05	5.61e-05	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	4.2e-05	5.24e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—AKT1—atherosclerosis	4.08e-05	5.09e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—IL6—atherosclerosis	3.98e-05	4.96e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—IL6—atherosclerosis	3.69e-05	4.61e-05	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	3.67e-05	4.58e-05	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	3.41e-05	4.25e-05	CbGpPWpGaD
